HELLEDAY; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for HELLEDAY; Thomas.The latest application filed is for "method for treating cancer using a combination of chk1 and atr inhibitors".

Company Profile

6.12.20

HELLEDAY; Thomas - Stockholm SE
HELLEDAY; Thomas - Solna SE
HELLEDAY; Thomas - STOCKSUND SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Treating Cancer Using A Combination Of Chk1 And Atr Inhibitors App 20220249489 - HELLEDAY; Thomas ; et al.	2022-08-11
Use Of Rnai Inhibiting Parp Activity For The Manufacture Of A Medicament For The Treatment Of Cancer App 20220062286 - Helleday; Thomas	2022-03-03
Method for treating cancer using a combination of Chk1 and ATR inhibitors Grant 11,179,394 - Helleday , et al. November 23, 2	2021-11-23
Novel Functionalized Purine-2,6-diones And Their Use In Medicine App 20210128566 - PAGE; Brent ; et al.	2021-05-06
2,6-diamino-3,4-dihydropyrimidin-4-one Derivatives And Use Thereof In Therapy App 20210052587 - BENGTSSON; Christoffer ; et al.	2021-02-25
Substituted Benzodiazoles And Use Thereof In Therapy App 20210002250 - C ZARES-KORNER; Armando ; et al.	2021-01-07
Use Of Rnai Inhibiting Parp Activity For The Manufacture Of A Medicament For The Treatment Of Cancer App 20200237762 - Helleday; Thomas	2020-07-30
MTH1 inhibitors for treatment of inflammatory and autoimmune conditions Grant 10,632,125 - Scobie , et al.	2020-04-28
MTH1 inhibitors for treatment of cancer Grant 10,179,790 - Scobie , et al. Ja	2019-01-15
Pyrimidine-2,4-diamine derivatives for treatment of cancer Grant 10,174,029 - Scobie , et al. J	2019-01-08
Mth1 Inhibitors For Treatment Of Inflammatory And Autoimmune Conditions App 20190000856 - Scobie; Martin ; et al.	2019-01-03
MTH1 inhibitors for treatment of inflammatory and autoimmune conditions Grant 10,064,869 - Scobie , et al. September 4, 2	2018-09-04
Pyrimidine-2,4-diamine Derivatives For Treatment Of Cancer App 20180170929 - SCOBIE; Martin ; et al.	2018-06-21
Bisarylsulfonamides useful in the treatment of inflammation and cancer Grant 10,000,449 - Martinsson , et al. June 19, 2	2018-06-19
Pyrimidine-2,4-diamine derivatives for treatment of cancer Grant 9,944,640 - Scobie , et al. April 17, 2	2018-04-17
Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer App 20180000822 - Helleday; Thomas	2018-01-04
Heterocyclic Compounds As Dctpp1 Modulators App 20170305893 - LLONA-MINGUEZ; Sabin ; et al.	2017-10-26
Pyrimidine-2,4-diamine Derivatives For Treatment Of Cancer App 20170217961 - SCOBIE; MARTIN ; et al.	2017-08-03
Mth1 Inhibitors For Treatment Of Cancer App 20170197976 - Scobie; Martin ; et al.	2017-07-13
Mth1 Inhibitors For Treatment Of Inflammatory And Autoimmune Conditions App 20170196873 - Scobie; Martin ; et al.	2017-07-13
Pyrimidine-2,4-diamine derivatives for treatment of cancer Grant 9,604,937 - Scobie , et al. March 28, 2	2017-03-28
Bisarylsulfonamides Useful In The Treatment Of Inflammation And Cancer App 20160221938 - MARTINSSON; Jessica ; et al.	2016-08-04
Pyrimidine-2,4-Diamine Derivatives for Treatment of Cancer App 20160002175 - Scobie; Martin ; et al.	2016-01-07
Method For Treating Cancer Using A Combination Of Chk1 And Atr Inhibitors App 20150359797 - Helleday; Thomas ; et al.	2015-12-17
Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer App 20150005327 - Helleday; Thomas	2015-01-01
Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer Grant 8,859,562 - Helleday October 14, 2	2014-10-14
Therapeutic compounds Grant 7,531,530 - Helleday , et al. May 12, 2	2009-05-12
Therapeutic compounds Grant 7,351,701 - Helleday , et al. April 1, 2	2008-04-01
Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer App 20070179160 - Helleday; Thomas	2007-08-02
Therapeutic compounds App 20070072841 - Helleday; Thomas ; et al.	2007-03-29
Therapeutic compounds App 20050143370 - Helleday, Thomas ; et al.	2005-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.